End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
181,000.00 KRW | +1.51% |
|
+0.44% | -3.47% |
Feb. 04 | South Korean Shares Rally on US Tariff Delay; Celltrion Shares Rise 1% on FDA Approval for ACTEMRA Biosimilar | MT |
Feb. 03 | Celltrion Secures FDA Approval for AVTOZMA Tocilizumab Biosimilar | MT |